These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 17376299

  • 21. CYP3A5*3 and MDR-1 C3435T single nucleotide polymorphisms in six Chinese ethnic groups.
    Lai Y, Zhang J, Wang YX, Wang XD, Li JL, Wang YH, Zeng YJ, Huang M.
    Pharmazie; 2011 Feb; 66(2):136-40. PubMed ID: 21434577
    [Abstract] [Full Text] [Related]

  • 22. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
    Azarpira N, Aghdaie MH, Behzad-Behbahanie A, Geramizadeh B, Behzadi S, Malekhoseinie SA, Raisjalal GH, Rahsaz M, Pourgholami A, Sagheb F.
    Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
    [Abstract] [Full Text] [Related]

  • 23. Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms.
    Li D, Gui R, Li J, Huang Z, Nie X.
    Transplant Proc; 2006 Nov; 38(9):2850-2. PubMed ID: 17112846
    [Abstract] [Full Text] [Related]

  • 24. Study of the association of -667 aquaporin-2 (AQP-2) A/G promoter polymorphism with the incidence and clinical course of chronic kidney disease in Korea.
    Kang SW, Kim YW, Kim YH, Sohn HS, Joo H, Kim E.
    Ren Fail; 2007 Nov; 29(6):693-8. PubMed ID: 17763164
    [Abstract] [Full Text] [Related]

  • 25. Genotype and allele frequencies of MDR1 gene C1236T polymorphism in a Turkish population.
    Gümüş-Akay G, Rüstemoğlu A, Karadağ A, Sunguroğlu A.
    Genet Mol Res; 2008 Oct 28; 7(4):1193-9. PubMed ID: 19048498
    [Abstract] [Full Text] [Related]

  • 26. The genetic variability of MDR1 C3435T polymorphisms in four Southern Chinese populations.
    Dong Q, Xu B, Tan Y, Liu Z, Tian L, Zhang B, Lin CK, Kung HF, Sung JJ, He ML.
    Biomed Pharmacother; 2009 Nov 28; 63(9):658-62. PubMed ID: 18926661
    [Abstract] [Full Text] [Related]

  • 27. Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease.
    Bellini MH, Figueira MN, Piccoli MF, Marumo JT, Cendoroglo MS, Neto MC, Dalboni MA, Batista MC, Goes MA, Schor N.
    Nephrology (Carlton); 2007 Jun 28; 12(3):289-93. PubMed ID: 17498125
    [Abstract] [Full Text] [Related]

  • 28. The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease.
    Testa A, Benedetto FA, Spoto B, Pisano A, Tripepi G, Mallamaci F, Malatino LS, Zoccali C.
    Nephrol Dial Transplant; 2006 Jul 28; 21(7):1921-6. PubMed ID: 16554320
    [Abstract] [Full Text] [Related]

  • 29. Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study.
    Jamison RL, Shih MC, Humphries DE, Guarino PD, Kaufman JS, Goldfarb DS, Warren SR, Gaziano JM, Lavori P, Veterans Affairs Site Investigators.
    Am J Kidney Dis; 2009 May 28; 53(5):779-89. PubMed ID: 19272686
    [Abstract] [Full Text] [Related]

  • 30. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.
    Buraczynska M, Ksiazek P, Zukowski P, Benedyk-Lorens E, Orlowska-Kowalik G.
    Clin Immunol; 2009 Aug 28; 132(2):285-90. PubMed ID: 19428307
    [Abstract] [Full Text] [Related]

  • 31. [The research on the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter with its effect of preventing ESRD patients from microinflammation and arteriosclerosis].
    Wu HC, Ling H, Na SP, Xie RJ.
    Zhonghua Yi Xue Za Zhi; 2005 Aug 03; 85(29):2076-80. PubMed ID: 16313808
    [Abstract] [Full Text] [Related]

  • 32. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
    Buraczynska M, Swatowski A, Buraczynska K, Dragan M, Ksiazek A.
    Clin Sci (Lond); 2009 Jan 03; 116(1):81-6. PubMed ID: 18518860
    [Abstract] [Full Text] [Related]

  • 33. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis.
    Buraczynska M, Jozwiak L, Ksiazek P, Borowicz E, Mierzicki P.
    Transl Res; 2007 Aug 03; 150(2):101-5. PubMed ID: 17656329
    [Abstract] [Full Text] [Related]

  • 34. Polymorphism in methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and apolipoprotein E in hemodialysis patients.
    Al-Muhanna F, Al-Mueilo S, Al-Ali A, Larbi E, Rubaish A, Abdulmohsen MF, Al-Zahrani A, Al-Ateeq S.
    Saudi J Kidney Dis Transpl; 2008 Nov 03; 19(6):937-41. PubMed ID: 18974580
    [Abstract] [Full Text] [Related]

  • 35. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.
    Loh PT, Lou HX, Zhao Y, Chin YM, Vathsala A.
    Transplant Proc; 2008 Jun 03; 40(5):1690-5. PubMed ID: 18589174
    [Abstract] [Full Text] [Related]

  • 36. Multidrug resistance in patients undergoing resective epilepsy surgery is not associated with C3435T polymorphism in the ABCB1 (MDR1) gene.
    Dericioglu N, Babaoglu MO, Yasar U, Bal IB, Bozkurt A, Saygi S.
    Epilepsy Res; 2008 Jul 03; 80(1):42-6. PubMed ID: 18436433
    [Abstract] [Full Text] [Related]

  • 37. Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients.
    Kato S, Lindholm B, Axelsson J, Qureshi RA, Barany P, Heimbürger O, Gustafsson JA, Stenvinkel P, Nordfors L.
    Nephrol Dial Transplant; 2007 Sep 03; 22(9):2571-7. PubMed ID: 17452407
    [Abstract] [Full Text] [Related]

  • 38. Effects of genetic polymorphisms of the renin-angiotensin system in children with nephrotic syndrome.
    Tabel Y, Berdeli A, Mir S, Serdaroğlu E, Yilmaz E.
    J Renin Angiotensin Aldosterone Syst; 2005 Dec 03; 6(3):138-44. PubMed ID: 16525944
    [Abstract] [Full Text] [Related]

  • 39. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease.
    Babel N, Gabdrakhmanova L, Hammer MH, Schoenemann C, Skrypnikov V, Poliak N, Volk HD, Reinke P.
    J Nephrol; 2006 Dec 03; 19(6):802-7. PubMed ID: 17173255
    [Abstract] [Full Text] [Related]

  • 40. Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease.
    Reiterová J, Merta M, Stekrová J, Cabartová Z, Cibulka R, Maixnerová D, Rysavá R, Ríhová Z, Tesar V, Motán J.
    Kidney Blood Press Res; 2006 Dec 03; 29(3):182-8. PubMed ID: 16943682
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.